You just read:

Sangamo BioSciences Presents New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storge Disorders at Annual Meeting of the American Society of Gene and Cell Therapy

News provided by

Sangamo BioSciences, Inc.

May 18, 2015, 07:00 ET